Search hospitals > Illinois > Orland Park
University of Chicago Medicine-Orland Park
Claim this profileOrland Park, Illinois 60462
Global Leader in Cancer
Global Leader in Recurrence
Conducts research for Breast Cancer
Conducts research for Tumors
Conducts research for Adenocarcinoma
110 reported clinical trials
27 medical researchers
Summary
University of Chicago Medicine-Orland Park is a medical facility located in Orland Park, Illinois. This center is recognized for care of Cancer, Recurrence, Breast Cancer, Tumors, Adenocarcinoma and other specialties. University of Chicago Medicine-Orland Park is involved with conducting 110 clinical trials across 292 conditions. There are 27 research doctors associated with this hospital, such as Rita Nanda, MD, Ardaman Shergill, MD, Christine M. Bestvina, and John Moroney, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Recurrence
Global LeaderStage IV
Stage III
Stage I
Top PIs
Rita Nanda, MDUniversity of Chicago Comprehensive Cancer Center7 years of reported clinical research
Expert in Breast Cancer
Studies Cancer
24 reported clinical trials
47 drugs studied
Ardaman Shergill, MDUniversity of Chicago Comprehensive Cancer Center3 years of reported clinical research
Studies Colorectal Cancer
Studies Adenocarcinoma
23 reported clinical trials
61 drugs studied
Christine M. BestvinaUniversity of Chicago Comprehensive Cancer Center5 years of reported clinical research
Expert in Non-Small Cell Lung Cancer
Expert in Lung Cancer
18 reported clinical trials
33 drugs studied
John Moroney, MDUniversity of Chicago4 years of reported clinical research
Expert in Ovarian Cancer
Studies Ovarian Tumors
16 reported clinical trials
37 drugs studied
Clinical Trials running at University of Chicago Medicine-Orland Park
Breast Cancer
Cancer
Prostate Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Renal Cell Carcinoma
Diffuse Large B-Cell Lymphoma
Bladder Carcinoma
Bladder Cancer
Squamous Cell Carcinoma
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of Chicago Medicine-Orland Park?
University of Chicago Medicine-Orland Park is a medical facility located in Orland Park, Illinois. This center is recognized for care of Cancer, Recurrence, Breast Cancer, Tumors, Adenocarcinoma and other specialties. University of Chicago Medicine-Orland Park is involved with conducting 110 clinical trials across 292 conditions. There are 27 research doctors associated with this hospital, such as Rita Nanda, MD, Ardaman Shergill, MD, Christine M. Bestvina, and John Moroney, MD.